United Kingdom (UK) Active Pharmaceutical Ingredient (API) Market Overview, 2027

UK Active Pharmaceutical Ingredients Market Size, Share, Trend & Market Analysis By Type, By Distribution Channel, By End User, Competition, Forecast & Opportunities.

The United Kingdom is one of the nations with both modern parliamentary practises and an industrial revolution. The country has a population of around 66.79 billion. The country is rich in a number of natural resources like coal, tin, limestone, iron ore, salt, clay, etc. Construction, agriculture, services, and tourism are the major sectors that make the country rich. The United Kingdom is a nation made up of a combination of historic England, Wales, and Scotland, as well as Northern Ireland. England, Wales, and Scotland also make up the nation known as Great Britain. The UK pharmaceutical market is also known to be among the global top 10 national markets. The United Kingdom is also home to two of the world’s top fifteen companies, known as GlaxoSmithKline (GSK) and Astra Zeneca. According to the Bonafide Research report title, "UK Active Pharmaceutical Ingredients Market Overview, 2027," it is perceived that the UK API market is expected to grow at a CAGR of 6.57% during the upcoming forecasted years. The UK API market is being observed on the basis of three types of market, specifically synthesis type, on the basis of therapeutic application and on the basis of the manufacturer. Amongst all the synthesis types of market, it is being summed up with the synthetic and biotech APIs, where the biotech API is being estimated to gain ground in the UK API market, whereas, on the other hand, the synthetic API market is estimated to show a dominating position every year.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Furthermore, the market is observed on the basis of therapeutic application where the market size for API is about to show an increase in terms of CAGR of more than 8% from the oncology application. According to sources, it was observed that every 1 in 2 people has a risk of getting a lifetime cancer infection in the country. Meanwhile, on the manufacturer side, captive API is gaining traction as more and more companies invest in API manufacturing facilities. Merchant APIs are gaining ground slowly and steadily in the UK API market, as there are some rare APIs which cannot be found in the nation. As a result, the United Kingdom's API export partner is the United States. This partner is stated to be the third party. It is also estimated that this partnership will increase exports. Thus, the future for merchant API is expected to grow by more than 6% CAGR. The major boost in the API market globally came into existence with the outbreak of COVID-19. At this point, every nation was undergoing the numeric levels of crisis and also observing the loss of their citizens' lives. Therefore, to protect the citizens of the economy, every country started manufacturing the APIs and also started importing the APIs, like the UK. The UK market observed growth in the API market during this time. Many APIs were produced and experimented with. During COVID-19, the NHS helped to manage demand for drugs by ensuring clinicians did not write unnecessary prescriptions for a longer period of time and also giving the patients clear advice about the appropriate use of the drug. During COVID-19, vaccines were required to be tested. The vaccines were made up of the various APIs that led to the curing of COVID-19. So, with the support and cooperation of the stakeholders, the UK nation contributed to testing and diagnostics. This improvement in the methods and production capabilities will allow the UK to be the global leader. Furthermore, almost 41% of all pharmaceutical products are exported, whereas 30% are for domestic sale. The remaining substances are the substances that are being used in the production of the other pharmaceutical products. Considered in this report • Geography: United Kingdom • Historic Year: 2016 • Base year: 2021 • Estimated year: 2022 • Forecast year: 2027

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Arun Kalwani

Arun Kalwani

Research Analyst

Aspects covered in this report • UK active pharmaceutical ingredient market • Application wise API market analysis • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation Based on synthesis type of API in the report: • Synthetic API • Biotech API Based on therapeutic application type of API in the report: • Communicable diseases • Oncology • Diabetes • Cardiovascular diseases • Pain management • Respiratory diseases • Other therapeutic application

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Arun Kalwani

By Type of manufacturer in the report: • Captive API • Biotech API The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analysing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to pharmaceutical industry, API manufacturing industries, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

Table of Contents

  • Table of Content
  • 1. Executive Summary
  • 2. Introduction
  • 2.1. Market Definition
  • 2.2. Market Scope & Segmentation
  • 2.3. Research Methodology
  • 3. UK Macro Economic Indicators
  • 4. UK Active Pharmaceutical Ingredients Market Category Analysis
  • 4.1. Key findings
  • 4.2. Market Drivers
  • 4.3. Market Restraints
  • 4.4. Policies & Certification
  • 4.5. Opportunities
  • 4.6. Value Chain Analysis
  • 4.7. Key Developments - 2021
  • 5. UK Active Pharmaceutical Ingredients Market Trends
  • 6. UK Active Pharmaceutical Ingredients Market Overview
  • 6.1. Market Size By Value
  • 6.2. Market Share
  • 6.2.1. By Synthesis Type
  • 6.2.2. By Therapeutic Application
  • 6.2.3. By Type of Manufacture
  • 7. UK Active Pharmaceutical Ingredients Market Segmentations
  • 7.1. UK Active Pharmaceutical Ingredients Market, By Synthesis Type
  • 7.1.1. UK Active Pharmaceutical Ingredients Market Size, By Synthetic API, 2016 - 2027F
  • 7.1.2. UK Active Pharmaceutical Ingredients Market Size, By Biotech API, 2016 - 2027F
  • 7.2. UK Active Pharmaceutical Ingredients Market, By Therapeutic Application
  • 7.2.1. UK Active Pharmaceutical Ingredients Market Size, By Communicable Diseases, 2016 - 2027F
  • 7.2.2. UK Active Pharmaceutical Ingredients Market Size, By Oncology, 2016 - 2027F
  • 7.2.3. UK Active Pharmaceutical Ingredients Market Size, By Diabetes, 2016 - 2027F
  • 7.2.4. UK Active Pharmaceutical Ingredients Market Size, By Cardiovascular Disease, 2016 - 2027F
  • 7.2.5. UK Active Pharmaceutical Ingredients Market Size, By Pain management, 2016 - 2027F
  • 7.2.6. UK Active Pharmaceutical Ingredients Market Size, By Respiratory Diseases, 2016 - 2027F
  • 7.2.7. UK Active Pharmaceutical Ingredients Market Size, By Other Therapeutic Applications, 2016 - 2027F
  • 7.3. UK Active Pharmaceutical Ingredients Market, By Type of Manufacture
  • 7.3.1. UK Active Pharmaceutical Ingredients Market Size, By Captive API, 2016 - 2027F
  • 7.3.2. UK Active Pharmaceutical Ingredients Market Size, By Merchant API, 2016 - 2027F
  • 8. UK Active Pharmaceutical Ingredients Market Opportunity Assessment
  • 8.1. By Active Pharmaceutical Ingredients, 2022F to 2027F
  • 8.2. By Therapeutic Application, 2022F to 2027F
  • 8.3. By Type of Manufacture, 2022F to 2027F
  • 9. Competitive Landscape
  • 9.1. Porter's Five Forces
  • 9.2. Company Profiles
  • 9.2.1. Company 1
  • 9.2.2. Company 2
  • 9.2.3. Company 3
  • 9.2.4. Company 4
  • 9.2.5. Company 5
  • 9.2.6. Company 6
  • 9.2.7. Company 7
  • 9.2.8. Company 8
  • 10. Strategic Recommendations
  • 11. Disclaimer?

List of Table
Table 1: UK Active Pharmaceutical Ingredients Market Size of Synthetic API (2016 to 2027F) (In USD billion)
Table 2: UK Active Pharmaceutical Ingredients Market Size of Biotech API (2016 to 2027F) (In USD billion)
Table 3: UK Active Pharmaceutical Ingredients Market Size of Communicable Diseases (2016 to 2027F) (In USD billion)
Table 4: UK Active Pharmaceutical Ingredients Market Size of Oncology (2016 to 2027F) (In USD billion)
Table 5: UK Active Pharmaceutical Ingredients Market Size of Diabetes (2016 to 2027F) (In USD billion)
Table 6: UK Active Pharmaceutical Ingredients Market Size of Cardiovascular Disease (2016 to 2027F) (In USD billion)
Table 7: UK Active Pharmaceutical Ingredients Market Size of Pain management (2016 to 2027F) (In USD billion)
Table 8: UK Active Pharmaceutical Ingredients Market Size of Respiratory Diseases (2016 to 2027F) (In USD billion)
Table 9: UK Active Pharmaceutical Ingredients Market Size of Other Therapeutic Applications (2016 to 2027F) (In USD billion)
Table 10: UK Active Pharmaceutical Ingredients Market Size of Captive API (2016 to 2027F) (In USD billion)
Table 11: UK Active Pharmaceutical Ingredients Market Size of Merchant API (2016 to 2027F) (In USD billion)
Table 12: Key Facts of Company 1
Table 13: Key Facts of Company 2
Table 14: Key Facts of Company 3
Table 15: Key Facts of Company 4
Table 16: Key Facts of Company 5
Table 17: Key Facts of Company 6
Table 18: Key Facts of Company 7
Table 19: Key Facts of Company 8

List of Figure
Figure 1: UK Active Pharmaceutical Ingredients Market Size By Value 2016 to 2027F (In USD billion)
Figure 2: UK Active Pharmaceutical Ingredients Market Share By Volume By Synthesis Type (2016, 2021 & 2027F)
Figure 3: UK Active Pharmaceutical Ingredients Market Share By Volume By Therapeutic Application (2016, 2021 & 2027F)
Figure 4: UK Active Pharmaceutical Ingredients Market Share By Type of Manufacture (2016, 2021 & 2027F)
Figure 5: Market Attractiveness Index, By Synthesis Type
Figure 6: Market Attractiveness Index, By Therapeutic Application
Figure 7: Market Attractiveness Index, By Type of Manufacture
Figure-8: Porter's Five Forces Meter of Active Pharmaceutical Ingredients Industry in UK

Why Bonafide Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology
92%
Data Collection Techniques
97%
Our Research Team & Data Sourcing
93%
Data Science & Analytical Tools
81%
Data Visualization & Presentation Skills
86%
Project/ Report Delivery & After Sales Services
88%
Logo

United Kingdom (UK) Active Pharmaceutical Ingredient (API) Market Overview, 2027

We are friendly and approachable, give us a call.